Stay updated on ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page
- Check3 days agoChange DetectedThe page now renders a 403 Forbidden error, with the site header/footer visible, replacing the previous study details and navigation and indicating access to the study record is blocked.SummaryDifference18%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe change adds Revision: v3.6.6 and removes Revision: v3.6.5 from the page, indicating a new version of the study record page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows a new Revision: v3.6.5, and several footer items were removed: a Link to results on the Astellas Clinical Study, the sponsor name Astellas Pharma Inc, the Helpful Links Provided by section, and the previous Revision: v3.6.4 reference.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision label updates from v3.6.3 to v3.6.4, indicating a new version of the page. This reflects a minor revision to the page metadata rather than changes to the study details or layout.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now reflects the latest revision number (v3.6.3). This indicates a page metadata update without impacting the study content or functionality.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing v3.6.0, indicating a newer release of the site software. This appears to be a maintenance update rather than a substantive change to the information presented.SummaryDifference0.0%

Stay in the know with updates to ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.